HLA G PEPTIDES IN IMMUNE TOLERANCE
HLA G 肽在免疫耐受中的作用
基本信息
- 批准号:2673985
- 负责人:
- 金额:$ 24.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-01 至 1999-08-31
- 项目状态:已结题
- 来源:
- 关键词:MHC class I antigen SDS polyacrylamide gel electrophoresis affinity chromatography calcium flux complementary DNA cytokine disease /disorder model genetic transcription human tissue immune tolerance /unresponsiveness in situ hybridization laboratory mouse leukocyte activation /transformation molecular cloning pregnancy immunology protein kinase protein sequence protooncogene receptor binding spontaneous abortion synthetic peptide
项目摘要
The unique pattern of class I major histocompatibility complex (MHC)
antigen expression at the maternal/fetal interface is thought to play a
major role in protecting the fetus from rejection by the mother's immune
system. Trophoblasts, the only fetal tissue that comes into direct contact
with the mother, do not express polymorphic class I and II MHC antigens.
This may in part explain the lack of maternal immune response against the
fetus. Recently it was found that a non-classical MHC molecule, designated
HLA-G, is present on certain subpopulations of trophoblasts, suggesting
that the expression of this non-polymorphic MHC molecule plays an active
role in maternal/fetal tolerance. The transcript encoding HLA-G has been
shown to undergo alternative splicing to give rise to a full length form
as well as two smaller forms, all of which contain the alpha1 alpha helix.
In addition, some of these forms have been shown to be secreted by cells.
These observations, as well as studies from this laboratory using
synthetic peptides corresponding to specific regions of classical MHC
class I molecules, constitute the experimental basis for the hypothesis
that soluble HLA-G peptides contribute to maternal immune unresponsiveness
towards the fetus. A synthetic peptide corresponding to the entire alpha1
alpha helix (residues 60-84) of HLA-G inhibits T cell proliferation in
vitro and also blocks IL-2 production by T cells. The aims of this
proposal are to investigate the molecular mechanisms by which soluble HLA-
G peptides induce unresponsiveness and to investigate their role in
pregnancy. Specifically, studies are proposed: 1) to characterize the
pathways by which synthetic peptides corresponding to HLA-G transduce a
negative signal in human lymphocytes; 2) to identify the receptor to which
these peptides bind; and 3) to examine the effects of these peptides in a
rodent model of spontaneous abortion.
I类主要组织相容性复合物(MHC)的独特模式
孕产妇/胎儿界面处的抗原表达被认为可以发挥
保护胎儿免于被母亲免疫拒绝的主要作用
系统。滋养细胞,这是唯一直接接触的胎儿组织
与母亲一起,不要表达I类和II类MHC抗原。
这可能部分解释了对孕产妇免疫反应的缺乏
胎儿。最近发现,指定的非古典MHC分子
HLA-G,存在于滋养细胞的某些亚群中,表明
这种非晶状体MHC分子的表达发挥了活性
在母亲/胎儿耐受性中的作用。编码HLA-G的笔录已经
显示出可替代的剪接以产生全长形式
以及两个较小的形式,所有形式都包含alpha1 alpha螺旋。
另外,其中一些形式已被细胞分泌。
这些观察结果以及该实验室的研究
对应于经典MHC特定区域的合成肽
I类分子,构成了假设的实验基础
可溶性HLA-G肽有助于产妇免疫反应症
朝向胎儿。与整个alpha1相对应的合成肽
HLA-G的α螺旋(残基60-84)抑制T细胞增殖
体外,还可以阻止T细胞产生IL-2。这个目的
建议是研究可溶性HLA-的分子机制
G肽会引起无反应性,并调查其在
怀孕。具体而言,提出了研究:1)表征
合成肽对应于HLA-G转导A的途径
人淋巴细胞中的阴性信号; 2)识别受体
这些肽结合; 3)检查这些肽在A中的作用
自发流产的啮齿动物模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carol A. Clayberger其他文献
Carol A. Clayberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carol A. Clayberger', 18)}}的其他基金
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation
结核分枝杆菌 CTL 表位:疫苗设计/评估
- 批准号:
6841212 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
Granulysin Derived Immunotherapeutics for Biodefense
用于生物防御的颗粒溶素衍生免疫疗法
- 批准号:
6690551 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation
结核分枝杆菌 CTL 表位:疫苗设计/评估
- 批准号:
6572695 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation
结核分枝杆菌 CTL 表位:疫苗设计/评估
- 批准号:
7014018 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
Granulysin Derived Immunotherapeutics for Biodefense
用于生物防御的颗粒溶素衍生免疫疗法
- 批准号:
7009226 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
M Tuberculosis CTL Epitopes: Vaccine Design/Evaluation
结核分枝杆菌 CTL 表位:疫苗设计/评估
- 批准号:
6701338 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
Granulysin Derived Immunotherapeutics for Biodefense
用于生物防御的颗粒溶素衍生免疫疗法
- 批准号:
6847413 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
Granulysin Derived Immunotherapeutics for Biodefense
用于生物防御的颗粒溶素衍生免疫疗法
- 批准号:
6804679 - 财政年份:2003
- 资助金额:
$ 24.48万 - 项目类别:
相似海外基金
HLA classl complex expression in breast cancer immunity
乳腺癌免疫中HLA classl复合物的表达
- 批准号:
7069061 - 财政年份:2005
- 资助金额:
$ 24.48万 - 项目类别:
HLA class l complex expression in breast cancer immunity
乳腺癌免疫中 HLA I 类复合物的表达
- 批准号:
6906817 - 财政年份:2005
- 资助金额:
$ 24.48万 - 项目类别: